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INTRODUCTION 
 
 Myopia / short sightedness is a refractive error in which the parallel 
rays of light from infinity come to focus in front of the retina when the eye is 
at rest, thus grossly reducing the vision.  Myopia could be axial due to 
elongation of anteroposterior diameter of the eyeball or curvature myopia 
due to increase in radius of curvature of the cornea; and index myopia due 
to change in refractive index of lens, cornea, aqueous and vitreous, thus 
increasing the dioptric power of the eye.     
Photorefractive keratectomy (PRK) consists of the application of 
energy ofthe ultraviolet range generated by an argon fluoride (ArF) excimer 
laser to the anterior corneal stroma to change its curvature and, thus, to 
correct a refractive error. The physical process of remodeling the corneal 
stroma by ultraviolet (193 nm wavelength) high-energy photons is known 
as photoablation.  
History of the Procedure: During the 1980s, several applications of 
the 193-nm ArF excimer laser were investigated, including its use on 
human corneas for the correction of refractive errors. In 1988, Munnerlyn, 
Kroons, and Marshall reported an algorithm relating diameter and depth of 
the ablation to the required dioptric change.  
McDonald performed the first excimer PRK for the correction of 
myopia on a normally sighted human eye in the United States. That same 
year, the Food and Drug Administration (FDA) organized a 3-phase trial, 
the PRK study (which ended in 1996), to demonstrate the safety, 
predictability, and stability of PRK for the treatment of myopia. At the end 
of this trial, 2 ophthalmic companies, VISX and Summit, were allowed to 
manufacture excimer lasers for widespread use in the United States. Since 
then, Nidek also has obtained approval for the manufacture of excimer 
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lasers in the United States, and several hundred thousand patients have 
undergone this procedure throughout the world. The first excimer lasers 
used to perform PRK in the late 1980s have been improved significantly in 
terms of size, efficiency, and accuracy. 
Pathophysiology: 
 The mechanism of ablation of the excimer laser appears to be 
photochemical in nature and is known as photochemical ablation or 
ablative photodecomposition. This highly localized tissue interaction is 
based on the fact that each photon produced by the ArF excimer laser has 
6.4 eV of energy, enough to break covalent bonds.  
 The efficacy and success of PRK depends largely on the type of 
laser platform in use.  Current fifth generation systems use a very rapidly 
repetitive and extremely small spot delivery with automated tracking of the 
eye movements to ensure precise treatment. 
The intramolecular bonds of exposed organic macromolecules are 
broken when a large number of high-energy 193-nm photons are absorbed 
in a short time. The resulting fragments rapidly expand and are ejected 
from the exposed surface at supersonic velocities. This mechanism 
explains why only the irradiated organic materials are affected, whereas 
the adjacent areas are not affected.  
The return of corneal innervation up to 5 years after PRK was 
measured. Corneal subbasal nerve density does not recover to near 
preoperative densities until 2 years after PRK, as compared to 5 years 
after laser in situ keratomileusis (LASIK). 
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AIM OF THE STUDY 
 
 
 
 To study the outcome of Photo Refractive keratectomy performed 
inpatients with low to moderate myopia using Mel 80 Excimer laser 
System. 
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REVIEW OF LITERATURE 
Corneal Anatomy 
 
 
 
 
Cornea has five layers(3) 
  Epithelium (30-50)mu 
  Bowmans Membrane (10-14)mu 
  Stroma (500-700mu) 
  Descemets Membrane (3-12) 
  Endothelium (4-6) 
 
 5
 The average corneal diameter is 11.5mm (vertical) and 12mm 
horizontal. 
1. Epithelium is stratified squamous and nonkeratinised and comprises  
o Single layer of columnar cells (basal) 
o 2 to3 round wing cells 
o 2 layers of squamous surface cells 
 
2. Bowman layer is the acellular superficial layer of the stroma, which 
scars when damaged.(3) 
3. The stroma makes up 90% of corneal thickness comprised of 
regularly oriented layers of collagen fibrils whose spacing is 
maintained by proteoglycan ground substance (chondroitin sulphate 
and keratin sulphate) with interspersed modified fibroblasts. 
4. Descemet’s membrane- fine latticework of collagen fibrils. 
5. Endothelium- single layer of hexagonal cells.  It plays a vital role in 
maintaining corneal deturgescence but does not regenerate. 
 
The major optical power of the eye is the air-tear film interface. (1). 
 
 The optical power of the eye derives primarily from anterior corneal 
curvature, which produces 2/3 of eye’s refractive power accounting for 
+48D.  By altering corneal shape, keratorefactory status of the eye can be 
modified.(4) 
 
 If the central cornea is steeper than its periphery the cornea shape is 
prolate and when the central cornea is flatter than the periphery, the 
corneal shape is oblate.  Prolate cornea reduces spherical aberrations 
while the oblate shape increases it.(4) 
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OPTICAL METHODS((4) 
 
1. Pachymetry:  involves measuring of corneal thickness, which is an 
indirect indication of the integrity of the corneal endothelium.  The 
thickness of the cornea is greatest at the limbus where it ranges 
from 0.7 to 0.9mm.  Normal central corneal thickness is 0.49 to 
0.56mm.  Readings of 0.6mm or more are suggestive of endothelial 
disease. 
2. Specular Microscopy:  involves photography of the corneal 
endothelium and subsequent analysis of cellular characteristics such 
as size, shape, density and distribution.  The normal endothelium 
consists of regular hexagonal cells.  The normal cell density is 3000 
cells per sq.mm.  Counts of below 1000 per sq.mm is associated 
with a significant risk of endothelial decompensation.(4) 
3.  Keratometry:  involves measurement of the curvature of the 
anterior surface of cornea. 
a.  Optical Principles:- 
The cornea acts as a convex mirror with fixed curvatures in 
each meridian.  This allows the position of two vertical and two 
horizontal points projected by the instrument to the reflected of the 
corneal surface.  The radius is then measured in millimeters and 
converted to diopters. 
b.  Limitations:- 
 The assumption that the cornea is a sphero-cylindrical 
surface with a single radius of curvature in each 
meridian and with major and minor axes at 90 degrees 
to each other. 
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 Keratometry measures only five points approximately 
3mm apart and provides no information about the 
cornea central or peripheral to the points measured. 
 Mild corneal surface irregularities can cause more 
distortion that compromises accuracy.  Keratometry is 
therefore of limited use for measuring corneas that are 
not spherocylindrical, as frequently occurs in patients 
seeking refractive surgery, keratoconus and several 
other corneal abnormalities. 
      4.  Corneal Topography:  utilising computerized videokeratoscopy, it 
provides a colour-coded map of the corneal surface.  The dioptric powers 
of the steepest and flattest meridia and their axes are also calculated and 
displayed.(1) 
 
a) Indications 
 
1. In all patients seeking laser refractive surgery for the corneal 
curvature and to quantify irregular astigmatism and corneal 
warpage associated with contact lens wear, if any. 
2. To diagnose early keratoconus for the froste KC and other 
ectactic corneal disorders. 
3. To evaluate post operative changes in corneal shape after 
refractive surgery, corneal grafting or cataract extraction. 
b) Scales 
       1.  Absolute scales have fixed end points and each individual 
colour represents a specific dioptric power interval.  Most normal 
corneas remain within the yellow-green spectrum of scale.   
An absolute scale should always be used to facilitate 
comparison over time and between patients. 
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2. Relative (normalised) scales are not fixed and vary 
according to the dioptric range of individual cornea. 
 
 
c) Interpretation(3) 
Can be perfected only through practice.  It depends on  
1. Reliability of the map. 
2. Position of the pupil in relation to curvature pattern 
display. 
 
ERRORS OF REFRACTION(3) 
 
 In normal individuals, parallel rays of light are focused on the retina.  
This state of refraction is called Emmetropia.  If in a state of rest, the 
parallel rays of light from infinity are focused either in front or behind the 
sensitive layer of the retina in one or both meridian, it is termed ametropia. 
 
Ametropia includes 
 
¾ Myopia 
¾ Hypermetropia 
¾ Astigmatism 
 
MYOPIA(3) 
 
 Short sightedness is a type of refractive error in which parallel rays 
of light coming from infinity are focused in front of the retina when 
accommodation is at rest. 
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MECHANISM OF PRODUCTION(3) 
 
1) Axial myopia results from increase in anteroposterior length of 
the eyeball.  It is the commonest. 
2) Curvatural myopia occurs due to increased curvature of the 
cornea, lens, or both. 
3) Positional myopia- anterior placement of crystalline lens in the 
eye. 
4) Index myopia- results increase in RI of crystalline lens 
associated with nuclear sclerosis. 
5) Myopia due to excessive accommodation occurs in patients 
with spasm of accommodation. 
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OPTICS OF MYOPIA 
 
 In myopes, a near object may be focused without any effort of 
accommodation if it is situated at the punctum remotum.  The image of an 
object at infinity is made up of circles of diffusion formed by diverging 
beam.  The nodal point in myopes is further away from the retina and 
image formed is larger in size.  Accomodation is of little value to myopes 
for higher errors.  The amplitude of accommodation is small.   
 
CLASSIFICATION OF MYOPIA(3) 
 
1. Congenital Myopia 
2. Simple Myopia 
3. Pathological Myopia 
4. Acquired Myopia 
 
CONGENITAL MYOPIA 
 
9 Is present since birth 
9 Diagnosed by the age of 2-3 years 
9 Seen in premature children or in various birth defects such as 
Marfan’s syndrome or Homocysteinuria 
9 Is unilateral and manifests as anisometropia 
9 Error is about 8 to 10 D associated with congenital squint 
9 Associated with cataract, microphthalmos, aniridia, 
megalocornea and congenital separation of retina 
 
SIMPLE MYOPIA 
 
 Simple or developmental myopia is the commonest type and 
considered as a physiological error and not associated with any disease of 
the eye. 
 11
 
Etiology:  It results from normal biological variations in development of the 
eye which may or may not be genetically determined. 
 
AXIAL MYOPIA:  results from the increase in the anteroposterior length of 
the eyeball.  It is the commonest form. 
 
CURVATURE MYOPIA:  results from increase in the radius of curvature of 
the cornea, lens or both.  A variation of 1 mm of radius of curvature results 
in a refractive change of 6 D. 
 
INDEX MYOPIA:  Here, changes in dioptric system may be due to change 
in refractive index of lens, cornea, aqueous or vitreous.  The dioptric power 
of the eye is too strong for the axial length of the eye. 
 
Clinical Symptoms: 
 
¾ Poor vision for distance (short sightedness) is the main symptom of 
myopia. 
¾ Asthenopic symptoms occur in patients with small degree of 
myopia.  Eyestrain develops due to dissociation between 
convergence and accommodation. 
¾ Fusion becomes weak and binocular vision is affected. 
¾ Patient starts suppressing one eye and suppressed eye deviates 
outwards. 
¾ Decreased visual acuity in indoor activities. 
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Signs: 
 
 The eye of simple myopia is large and prominent.  Chamber is deep 
and pupil reaction is sluggish.  Macula appears slightly nearer to disc.  
There may be divergent squint. 
 
PATHOLOGICAL / PROGRESSIVE / DEGENERATIVE MYOPIA(3) 
 
 It is a rapidly progressive error resulting in high myopia during early 
adult life, usually associated with degenerative changes in the eye. 
 It results from rapid axial growth of the eyeball outside the normal 
biological variation of development. 
 It is definitely linked to heredity and general growth process. 
 
Heredity factor:  Progressive myopia is familial and more 
common in races like the Chinese, Japanese, Arabs and 
Jews. 
Role of general growth process:  Factors like nutritional 
deficiency, debilitating diseases, endocrinal disturbances and 
indifferent general health also influence progress of myopia. 
 
  
CLINICAL PICTURE 
 
 Defective vision  
 Night blindness 
 Muscae volitantes 
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SIGNS 
 
   Eyes are more prominent 
   Anterior Chamber is deep 
   Cornea appears large 
   Pupil slightly large and sluggish 
   Refractive error increases by as much as 4D yearly and usually 
stabilizes at the age of 20. 
 
 
 
 
 
 
o Optic disc appears large and pale 
o Myopic crescent 
o Atrophy of retinal pigment epithelium and choriocapillaries- tigroid 
appearance due to visible prominent large choroidal vessels 
o Atrophic patches at macula 
o Foster Fuchs spot 
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o Cystoid degeneration 
o Posterior staphyloma 
o Posterior vitreous detatchment 
o Contraction of visual fields 
o ERG subnormal 
 
  
COMPLICATIONS 
 
¾ Retinal detachment 
¾ Complicated cataract 
¾ Vitreous haemorrhage 
¾ Choroidal haemorrhage 
 
TREATMENT(5) 
 
NON SURGICAL 
 
9 Spectacle correction with concave lens 
9 Contact lens 
 
SURGICAL 
 
9 Radial Keratotomy 
9 Photo-Refractive-Keratectomy 
9 LASIK 
9 Phakic IOLS Refractive Lens Exchange 
9 Intra corneal ring implantation for low myopia 
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HISTORY(3) 
 
 Refractive surgery has been used to correct myopia and 
hypermetropia for more than 40 years.  Conceptually, refractive corneal 
surgery attempts to remove, add or modify the corneal stroma, so that the 
radius of curvature of the anterior corneal interface is altered as desired. 
  
Based on the fundamental principle that cornea contributes twothirds 
of refracting power of the eye, Barraquer attempted to alter the tear film/ 
anterior cornea interface radius of curvature by adding or removing corneal 
tissue. 
Keratomileusis in situ- derived from the Greek word keras ( horn-
like=cornea) smileusis- carving. Keratomileusis in situ for myopia was the 
first to develop in late 1940.  The procedure involved raising a corneal flap 
and removing tissue from residual stromal bed.  Barraquer performed a 
free hand lamellar dissection of the anterior half of the cornea with a 
keratome.  Subsequently, refractive cut was attempted with second pass of 
the knife to remove stromal bed and cap was replaced with flattening of 
corneal curvature thus reducing myopia.  This procedure was abandoned 
due to many technical difficulties. 
 
 The gateway to Keratophakia opened in 1961, which involved 
steepening of central corneal curvature by placing a disc of tissue under 
the lamellar cap derived from alloplastic stromal disc harvested from a 
donor cornea. 
 
 This was seen a possible solution in aphakia, but with advent of IOL, 
interest in keratophakia subsided.        
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Freeze myopic Keratomileusis(3) 
 
 In an effort to overcome technical difficulties of manual cut, 
Barraquer used contact lens lathe to sculpture the frozen lamellar cap. 
Barraquer recognized that the culting speed and the relation between FOP 
and diameter of resection were factors directly affecting quality and depth 
of cut.  His efforts for more predictable and accurate cuts led to the 
development of applanator lenses, suction rings of various diameters and 
various heights of microkeratome tracks.  This work constituted the basis 
of future microkeratome evolution. 
 
Disadvantages: 
1. Learning curve was too steep with higher complication rate. 
2. Cryolathe was too expensive and complex to maintain. 
 
Epikeratoplasty 
 
 Epikeratophakia was introduced in1979 by Kaufmann and Werblin to 
avoid use of cryolathe.  They used preprocessed refractive lenticules.  A 
stromal disc was removed from the donor eye with microkeratome and was 
frozen and lathed into concave or convex lenses and then lyophilized and 
stored for later use.  It was intended for use in myopia, hypermetropia and 
keratoconus. 
 
Complications 
 
1. Persistent epithelial defect 
2. Epithelial ingrowth 
3. Melting, scarring 
4. Epithelialisation of donor lenticule 
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Barraquer-Krumeich Swinger (BKS) technique(17) 
 
 An improved microkeratome, a set of dyes and suction stand 
microkeratome was used to perform a total lamellar cap.  The cap was 
placed epithelial side down on suction rings for microkeratome to perform 
second cut on stromal aspect of cap.  The sculptured lamellar disc was 
finally sutured back to the bed.  The nonfreezing technique has more 
advantage over freeze techniques with rapid and comfortable recovery, 
preservation of fibroblasts and epithelium.  However, significant 
astigmatism could not be avoided. 
 
Automated lamellar keratoplasty 
 
 Development of automated geared microtome by Ruiz in 1980 
introduced Automated lamellar keratoplasty.  Speed of the cut could be 
controlled resulting in more even and consistent cuts. 
 
 The second cut was made on the bed.  The depth of second cut was 
adjusted by altering the height of suction ring and corneal cap was sutured 
back. 
 
Advantages 
 
9 Rapid recovery 
9 Efficacy in correcting high myopia 
9 Ease of use 
 
Disadvantages 
 
 High degree of irregular astigmatism 
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Photorefractive keratectomy(8) 
  
 It is a procedure of photoablation by Excimer laser which has been 
in use for the treatment of myopia, hypermetropia and astigmatism. 
  
 Photorefractive keratectomy has gained maximum success in 
myopic patients. 
 
Photorefractive keratectomy has become popular after Srinivasan, 
Braren and Trokel in 1983 thought that excimer laser can be used to cut 
the cornea. 
  
Photorefractive keratectomy gives good results from –2 to –6 D of 
myopia. 
 
Indications(7) 
 
1. Superficial scar with myopia 
2. basement membrane dystrophy with myopia 
3. myopia when unable to use a microkeratome because of high brow 
or tight lid with narrow palpebral fissures 
4. Glaucoma suspects 
5. cornea thinner than 500 microns 
 
Photorefractive keratectomy can be satisfactorily performed under 
topical anesthesia.  The center of the pupil is marked; the epithelium is 
removed by mechanical debridement with a blunt hockey knife followed 
by followed by ablation of corneal stroma with excimer laser.  
Reepithelialisation occurs in 3 to 4 days.  Improvements in the laser 
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profile, small spot size, flying spot technology and Gaussian curve in 
conjunction with mitomycin C have made it possible to treat higher 
degrees of myopia.  Epithelium can also be removed using alcohol or 
by excimer laser. 
  
Complications are rare which include 
 
1. Corneal haze and regression 
2. Night glare and halos 
3. Delayed epithelial healing 
4. Corneal ulceration 
5. Corneal infiltration 
6. Central islands 
7. Decentration af ablation zone 
 
LASIK(4) 
 Is a keratorefractive surgery that combines the precision of excimer 
laser photoablation  with advantages of an intrastromal procedure that 
maintains the integrity of Bowmans layer and overlying epithelium.  It was 
introduced, designed and developed at University of Crete and Verdin 
Oyannion Eye Institute of Crete in 1988. 
 
 Currently, this procedure is being considered the refractive surgery 
of choice for myopia because of its definite advantages over PRK and RK.  
LASIK can be used to correct upto –15D of myopia and upto –6D of 
astigmatism. 
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PHOTOREFRACTIVE KERATECTOMY(17) 
Indications 
¾ Superficial scar with myopia 
¾ Basement membrane dystrophy with myopia 
¾ Myopia when unable to use a microkeratome because of high brow 
or tight lid with narrow palpebral fissure 
¾ Cornea thinner than 500 microns  
 
Preoperative evaluation 
 
 Marguente Mc Donald MD of New Orleans, Louisiana performed the 
first PRK and has been one of the key surgeons responsible for extensive 
pioneering work in appropriate approach to PRK.(2)   
A thorough preoperative evaluation is of critical importance in 
achieving a successful outcome following refractive surgery.  During this 
evaluation, the surgeon decides if the patient is or not a good candidate for 
refractive surgery.(4) 
 
1. MEDICAL HISTORY:  It should include history of any systemic 
disease like diabetes, prior surgeries, connective tissue disorders, 
any immunocompromised states like HIV/ AIDS, drug history- 
isotretinold, somatripten, amiadarone, hormone replacement 
therapy. 
2. REALISTIC PATIENT EXPECTATION:  The ophthalmologist 
should explain in detail about the refractive results.  Patients should 
understand  will not prevent possible future ocular problems like 
cataract, glaucoma or retinal detachment.  Patients should be told 
that PRK is being done to decrease dependence on glasses and 
not to get rid of glasses. 
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3. Patient ocular history, blepharitis, recurrent erosion, dry eyes, 
retinal tears, detachment, use of glasses, stability of current 
refraction, contact lens history- types of contact lens, duration of 
contact lens use.  Patient should discontinue soft contact lens for at 
least three days to two weeks prior to surgery.  After 40 years, 
patients who have undergone refractive surgery will need 
presbyopic correction with glasses and this should be explained to 
the patient. 
4. Uncorrected visual acuity for distance and near should be 
measured to determine the amount of correction to be performed.  
Full cycloplegic refraction is mandatory.  A final subjective 
refraction using the autorefractometer, Wasca oberrometer values 
should be done by the ophthalmologist and refined using 
duochrome test.    
 
Pupil size(18) 
 
 Pupillary examination involving evaluating pupil size in bright room 
light and dim illumination any afferent papillary defect, various techniques 
to measure the size of the pupil- light amplification pupillometer, infrared 
pupillometer, Wasca aberrometer. 
 
 Large pupil  may be one of the risk factors for postoperative glare 
and halo after refractive surgery.  Optical zone should be0.25mmlarger 
than pupil diameter to prevent glare and haloes.   
 
Ocular motility, or confrontation fields(6) 
 
 Asymptomatic tropia and phoria may develop symptoms after 
surgery if change of refraction causes the motility status to break down.  
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Orthoptic evaluation should be done preoperatively.  Confrontation fields 
should be done in all patients. 
 
Intraocular pressure(7) 
 
 In patients with glaucoma, refractive surgery elevates the iIOP 
during the procedure, aggravating optic nerve damage.   
 
 Topical corticosteroid use after the proceduremay cause elevation of 
IOP in corticosteroid responders. 
 
Slit lamp Examination 
 
 Complete slit lamp examination of eye, lids, cornea and anterior 
segment should be performed to check for meibonites, stye, blepharitis, 
tear film stability, conjunctival scarring, pterygium, epithelial erosions, 
dystrophies, keratoconus or any opacities. 
 
Depth of anterior chamber, iris, look for cataract. 
 
Detailed Fundus Examination(1) 
 
 It is important to be certain that the posterior segment is normal.  
Special attention is given to the optic nerve (glaucoma, optic nerve 
drusen), peripheral retina (retinal tear, detachment, retinal holes, 
peripheral degeneration, high myopia) are at increased risk for retinal 
detachment. 
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Corneal Topography 
1. Pachymetry 
2. wavefront analysis 
 
Informed consent 
 
 After evaluation, the surgeon analyses all the information and 
discusses the findings with the patient.  Risks and benefits of various 
medical and surgical alternatives are discussed. 
 
Discussions with the patient should include 
 
1) Expected uncorrected visual acuity 
2) Risk of decreased BCVA, severe visual loss, glare haloes, dry 
eyes(rare) 
3) Patient shouldgivehis informed consent form well before the 
surgery. 
 
PROCEDURE(5) 
 
 In this technique to correct myopia, a central optical zone of anterior 
corneal stroma is photoablated using Excimer Laser to cause flattening of 
central cornea. 
 
Surgical steps are:- 
 
1. ANAESTHESIA:  PRK isperformed under topical anaesthesia. 
2. EPITHELIUM REMOVAL:  Deepithelialisation methods include 
mechanical debridement with blunthockey   knifeunder topical 
anaesthesia,   alcohol and photoablative deepithelialisation.  Attempt 
should be made to deepithelialise 0.5mm to 1mm larger area than 
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the desired ablative zone. The time lapsed from the removal of 
corneal epithelium to the application of laser energy should be 
minimized to prevent extreme drying or wetting of corneal surface.  
Always avoid leaving any residual islands of epithelium. 
3. ABLATION ZONE DIAMETER:  small ablative zones are known to 
cause symptomatic haloes while night driving.  Increasing 
experience in PRK has shown that the ideal diameter of ablation 
zone for myopia is 6mm and for hypermetropia is 9mm.(12) 
4. FIXATION AND CENTRATION OF THE ABLATION ZONE:  some 
surgeons use hand held suction  rings, while others promote the 
method of self fixation by the patient during ablation.  Fixation light 
on the microscope should be co axial with surgeon’s and patient’s 
line of vision. 
Co-axiality of fixation light should be maintained with the laser 
light also. It should always be explained to the patient that the 
clarity of fixation target will decline during ablation, but will be 
visible and that he should try to fix it.  It is always better to 
patch the fellow eye to prevent cross fixation.  Laser beam 
should be aimed at the center of the pupil.(12) 
   
5. CORNEAL ABLATION:  Multizone and multistep procedures are 
found advantageous since most cases have a tendency for 
regression.  A 1.5mm white tapered transition zone bordering the 
refractive zone of 4mm with overall diameter of 6-7mm usually 
results in better epithelial healing and lesser regression. 
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6. FLUENCE AND REPITITION RATE:  change in fluence and 
repetition rate affect not only the rate at which tissue is removed and 
the operation time, but also the surface morphology of the ablated 
corneal tissue. 
 
7. SCANNING LASER BEAM:  The laser device can be smaller and 
cheaper if small diameter circular or narrow slit beam is used for 
scanning the ablated area.(16) 
 
8. ASPHERIC ABLATIONS:  This is a unique advantage of PRK.  
Planned aspheric ablations are made in high myopia, which avoid 
central islands, thereby decreasing postoperative spherical 
aberrations.  Astigmatism may be naturally occurring, post traumatic, 
post infective and post surgical correction is done by ablating the 
superficial cornea in a cylindrical fashion known as toric 
photoablation. 
 
              The laser is centered and focused according to the 
manufacturer’s recommendations.  Although the excimer laser 
beam, a 193nm, is invisible to the human eye, a faint fluorescence of 
deep blue light is sometimes visible during stromal ablation. 
 
 The sound of the laser firing is the main feedback signal to the 
surgeon along with an alteration in light reflex as the stromal ablation 
progresses. 
 
 In mel 80 excimer laser the operating assistant  
(topass)displays the progress of laser ablation . 
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 In order to attempt to decrease the chance of postoperative 
corneal haze after enhancement of  PRK scar or after PRK is 
applied to LASIK flap, or in high myopes  a soaked pledget usually 
0.02mg/ml mitomycin can be placed on the ablated surface for 12 
seconds to two minutes at the end of laser exposure.  The cornea is 
then irrigated with balanced salt solution to remove excess 
mitomycin to avoid damage to limbal stem cells. 
 
Immediate post ablation methods: 
 
 After the procedure is completed, drops of antibiotic,BCL is 
placed an NSAID are instilled in the eye followed by a bandage soft 
contact lens. 
 
Subsequent postoperative care/(18) 
 The patient should be followed closely until the epithelium is 
completely healed, which usually occurs within 72 hrs.  As long as 
the bandagesoft contact lens is in place, patients are treated with 
topical broad spectrum antibiotics and NSAID, usually 4 times a day. 
  
The patients are admitted after PRK till BCL is removed / 
complete epithelial healing . 
 
 Studies have shown that corticosteroids are effective in 
limiting haze and myopic regression after PRK, particularly after 
higher myopic corrections when used after bandage soft lens 
removal.  Corticosteroid drops are tapered over 3 to 4 months 
depending on the corneal haze and refractive outcome.  Artificial 
tears are used frequently upto 6 months post PRK . 
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OUTCOMES(18) 
 
EVOLVING TECHNOLOGY: 
 
 As the early broad beam Excimer laser systems improved and 
as surgeon experience increased, PRK results improved markedly.  
The ablation zone diameter enlarged because small ablation zones, 
originally selected to limit depth of tissue removal, produced more 
haze and regression as well as glare and haloes.  The larger 
treatment diameter used today includes optical zones and aspheric 
peripheral bald zones improve both optical quality and refractive 
stability in myopia and hyperopic treatments. 
 
 Central islands have become less common with improvement 
in beam quality and with development of scanning excimer lasers. 
 
TRACKING DEVICES(18)  
 
 Two types of tracker technology exists: 
1. Closed loop:  High speed oscillating infrared beams scan across the 
edge of fixed dilated pupil.  The beams detect the abrupt change in 
reflected light at the edge of the pupil.  This signal then directs 
rapidly responding mirrors to create a space-stabilised image and 
the laser beam is located on the cornea on next image. 
2. Open loop:  Uses video to monitor the location of an infrared image 
of the pupil and to shift the laser beam accordingly. 
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COMPLICATIONS: 
 
1. OVERCORRECTION:  of more than +1.0D at one year occurs in 
less than 5% of myopes.  Myopic or hyperopic PRK undergoes 
regression for at least 3 to 6 months.  Refractive stability must be 
achieved before deciding whether overcorrection requires 
retreatment. 
2. UNDERCORRECTION:  occurs much more frequently at higher 
degree of myopia because of decreased predictability resulting from 
the greater frequency and severity of regression.  Regression is 
markedly increased with optical zones of less than 6mm 
diameter.(10) 
3. CENTRAL ISLANDS:  Kreuger RR, McDonnell PJ clinical analysis 
of steep central islands after excimer laser PRK Arch Ophthalmol 
1996 114.377-381 with computer assisted topographic analysis.  
Corneas show a central region of higher corneal refractive power 
compared to adjacent paracentral cornea.  These are the causes of 
undercorrection  and irregular astigmatism.(8) 
Many theories have been put forward to explain their 
formation.  These include: 
i. Shock wave formation and ejection of plume of gaseous and 
particulate debris, which interfere with subsequent proper 
delivery of laser. 
ii. Undesired optics of the laser or variation in beam 
homogeneity. 
iii. Differential hydration of the corneal tissue postoperatively. 
iv. Healing being non-uniform leads to greater epithelial 
hyperplasia centrally. 
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4. DECENTRATION OF THE ABLATION ZONE:  Usually occurs 
either due to poor alignment with patient fixation or due to eye 
movements during surgery.  These patients experience 
degeneration of optical performance.  Diplopia, glare haloes and 
induced astigmatism with loss of BCVA are the problems associated 
with decentration.(6) 
 
Larger decentrations may cause complaints of glare, haloes 
and decreased visual acuity.  The patient may experience 
more symptoms if the decentration zone is more than 1.0mm.  
Patients with larger pupil may experience symptoms with 
smaller amounts of decentration, because the edge of the 
decentered ablation will more easily be perceived within the 
patient’s visual axis.  It can be prevented by proper 
stabilization of the patient’s head and by alertness of the 
surgeon in stopping the ablation if the patient begins to lose 
fixation. 
5. OPTICAL ABERRATIONS:  Some patients report optical 
aberrations including glare,  ghost images and haloes.  These 
symptoms are more prevalent after treatment with smaller ablation 
zones and after higher attempted correction.  These complaints 
seem to be exacerbated at night and are more prevalent in young 
myopic patients with large papillary diameters due to an optical zone 
that is smaller than entrance pupil under conditions of dim 
illumination.  This problem can be treated with second ablation by 
increasing diameter to 6mm. sometimes night vision complaints 
spontaneously resolve 
6. CORNEAL HAZE:  Wound healing patterns after PRK can be 
separated into three groups. (5)  
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• Normal healers who have trace to 1+ haze and a refraction of 
0 to 1.0D at 1 month. 
• Inadequate healers who have no haze and a refraction 
>+1.0D beyond the target correction at 1 month. 
• Aggressive healers, whose have 1+ or greater haze that 
increases in month 2 and 3 accompanied by regression of the 
correction. 
• Subepithelial corneal haze typically appears several weeks 
after PRK, peaks in intensity at 1 to 2 months and gradually 
disappears during the following 6 to 12 months. 
• Late onset corneal haze that occurs several months or even 1 
year or more postoperatively after a prior period of relatively 
clear cornea. 
 
Histologic studies in animals with cornea haze after PRK demonstrate 
abnormal glycosaminoglycans and or nonlamellar collagen deposited in 
anterior stroma as a consequence of epithelial-stromal wound healing.  
Topical steroids are useful in resolving the level of haze as well as any 
refractive regression due to haze.  Excimer laser retreatment may be 
required in cases where have persists beyond 6 months and is associated 
with regression.(15) 
 
7. DELAYED EPITHELIAL HEALING:  Keratoconjuctivitis sicca, 
topical anti-inflammatory drugs, prophylactic antibiotic therapy and 
bigger debrided area are the commonly known causes for delayed 
epithelial healing.(10) 
8. RECURRENT EPITHELIAL EROSIONS:  There are known to 
occurs if epithelial defect made before ablation procedure is larger 
than the ablation zone. 
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9. CORNEAL INFILTRATION:  The sterile corneal infiltrates are 
usually focal but may be multicentric.  There appear days to weeks 
after surgery.  It they are central they may cause reduction in visual 
acuity. 
10. CORNEAL ULCERATION:  Patients getting bandage soft 
contact lens after PRK are prone for corneal ulcers.(15) 
11. DECREASED CORNEAL SENSATIONS:  patient with high 
myopia undergoing larger and deeper ablations show reduced 
sensitivity more than other.(9) 
 
Corticosteroid induced complication: 
A. Raised IOP is thought to be a result of one of postoperative 
corticosteroids topically.  Corticosteroid induced glaucoma 
occurs in 1.5% to 3% of patients using fluoromethasone.  25% 
of patient using dexamethasone. 
B. Other complication that have been reported after PRK are 
corticosteroid induced induced herpes simple virus keratitis, 
corticosteroid induced ptosis and corticosteroid induced 
cataract. 
 
12. DRY EYE:  condition occurs after PRK as a result of 
denervation with less severity and denervation.(10) 
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PATIENTS AND METHODS 
 
 Patients with low myopia (-1D to –6D) and moderate myopia (-6D to 
–14D) undergoing PRK using the Mel80 Excimer system at the cornea 
clinic, Institute of Ophthalmology, Joseph Eye Hospital, Trichy, between 
September 2005 and September 2006. 
 
Inclusion criteria 
 
9 Superficial scar with myopia 
9 Basement membrane dystrophy with myopia 
9 Myopia when unable to use a microkeratome because of high 
brow or tight lid with narrow palpebral fissure 
9 Cornea thinner than 500 microns 
9 Glaucoma suspects 
 
Exclusion criteria 
 
 
 Cataract 
 Immunocompromised patients(poor healing,increased risk of 
infection) 
 strabismus 
 Retinal detatchment 
 
 A standard protocol was used to collect and document all the details 
regarding the cases included in the study. 
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Detailed information about history, complaints, occupation of the 
patient was taken.  This included type of visual problem, duration of 
symptoms, duration of wearing glasses/ contact lens, frequency of 
changing glasses, any prior corneal surgery, trauma, any prolonged use of 
topical medications and any history of systemic disease.  
 
 A complete ocular examination was done for each patient which 
included uncorrected visual acuity, best corrected visual acuity following 
cycloplegic refraction, slit lamp examination, corneal topography, 
ultrasound pachymetry, papillary size, non contact tonometry, slit lamp 
biomicroscopy with a +90D, indirect ophthalmoscopy and Wasca 
aberrometer. 
 
 Antibiotic drops (Ofloxacin/ Gatifloxacin) 4 times a day prescribed 1 
day before surgery. 
 Patient was advised not to use deodorants, perfumes, flowers on the 
day of surgery to avoid attenuation of laser energy. 
 Patient was asked to wash face with soap and water 
 Ofloxacin eye drops and NSAID eye drops applied 3 times at 15 min. 
intervals 
 One drop proparicaine applied 20 min. before scheduled surgery 
 Patient was positioned on the laser bed and one more drop of 
propricaine applied 
 Eyelid margins were prepared with betadine (0.5%) 
 Head was draped with towel and speculum applied 
 Deepithelialisation was done with blunt hockey knife under topical 
anaesthesia 
 0.5 to 1.0 mm larger area than desired ablative zone was 
deepithelialised 
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 Hand held suction rings were used to fix during ablation 
 Fixation light on the microscope was coaxial with surgeon’s and 
patient’s line of vision 
 The fellow eye was fixed to prevent cross fixation 
 Laser beam was aimed at the center of the pupil 
 In Mel80 excimer laser, the operating assistant (TOPASS) displays 
the progress of laser ablation 
 In order to decrease the chance of postoperative corneal haze, after 
PRK, a soaked pledget with 0.2mg/ml of mitomycin was placed on 
the ablated surface for 12 seconds at the end of laser procedure 
 The cornea is then irrigated with BSS to remove excess mitomycin 
to avoid damage to limbal stem cells 
 After the procedure is completed, a drop of antibiotic and NSAID is 
instilled and bandage contact lens is placed 
 Patient is followed closely until the epithelium is healed in 72 hrs 
 As long as the bandage contact lens is in place, patients are treated 
with topical broad spectrum antibiotics and NSAIDs usually 4 times a 
day 
 Patients are discharged after removal of the bandage contact lens, 
after 3 days 
 The patient was asked to come for follow up after 6 months, when a 
thorough slit lamp examination was done and visual acuity and 
refraction recorded.  
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CORNEAL TOPOGRAPHY 
PACHYMETRY 
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WASCA ABERROMETER 
Mel 80 Excimer Laser Platform 
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First Day Postoperative Picture 
Three Months Postoperative Picture 
PRK 
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RESULTS: 
 
In this prospective, randomized study, 46 eyes of 23 patients 
belonging to the mild myopia group (-1 D to –6D), 44 eyes of 22 patients 
belonging to moderate group (-6D to –12D) who underwent PRK between 
the period of September 2005 to September 2006 at the Institute of 
Ophthalmology, Joseph Eye Hospital, Trichy, were included in the study. 
 
Age:   
 The mean age was 26.5. 
 The maximum number of patients were in the age group 18-38. 
In mild myopia group, 14 patients were in 18-25 age group. 
        9 patients were in 25-35 age group 
In moderate myopia group, 14 patients were in 18-25 age group. 
                4 patients were in 25-35 age group. 
                4 patients were in above 35 age group. 
 
Gender 
¾ In mild myopia group, 10 males and 13 females 
¾ In moderate myopia group, there were 7 males and15 females  
 
 
Laterality 
In 45 patients both eyes underwent the procedure 
 
Indications:  The most common complaints of the patients during 
presentation was defective vision and cosmetic. 
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Preoperative and postoperative visual acuity: 
 
 In mild myopia group, 33 eyes of 17 patients had preoperative 
uncorrected visual acuity between 6/9 to 6/60 and 13 eyes of 7 patients < 
5/60 with a mean of 0.16 and SD +/- 0.12.   
 The postoperative visual acuity in mild myopia- 40 eyes of 20 
patients had UCVA of 6/6 with a mean of 0.95 and SD +/- 0.152. 
 Paired T test value  
  P value less than <0.001 is statistically significant. 
 
 In moderate myopia group, 4 eyes of 2 patients had preoperative 
UCVA between 6/9 to 6/60 and 40 eyes of 20 patients had UCVA <5/60 
with a mean of 0.076 and SD +/-0.021.   
 The postoperative visual acuity in moderate myopic groups- 40 eyes 
of 20 patients had UCVA of 6/6 after 6 months.   
 5 eyes of 3 patients had UCVA between 6/24 and 6/9which did not 
improve to 6/6 with refraction.  They had a mean of 0.94 with SD +/-0.18. 
 Paired T test value 
  P value <0.001 is statistically significant. 
 
The mean preoperative spherical equivalent in low myopes  
  
 
 
 
MEAN
 
STANDARD DEVIATION
 
 
PREOP 
 
-3.07
 
 
          +/-2.3 
 
POSTOP
 
-0.18
 
          +/-0.32 
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The mean preoperative spherical equivalent in moderate myopes  
  
 
 
 
MEAN
 
STANDARD DEVIATION 
 
 
PREOP 
 
-9.15 
 
+/-3.3 
 
 
POSTOP 
 
-0.38 
 
+/-0.75 
 
 
It was found in preoperative and postoperative spherical equivalent in low 
to moderate myopes, paired T test, p value was <0.0001which was 
statistically significant. 
 
Pachymetry: 
 
 MEAN CORNEAL 
THICKNESS 
STANDARD 
DEVIATION 
LOW MYOPES 500.52 +/-25.8 
MODERATE 
MYOPES 
498.65 +/-31.16 
 
 5 eyes of 3 patients in moderate myopic group whose preoperative 
vision was between 6/36 and 6/9 did not show any improvement after the 
procedure or with final refraction and were found to be amblyopic.   
 22 eyes of 11 patients had epithelial defect during the procedure.  
There was postoperative stromal haze in these patients.  However, the 
stromal haze regressed postoperatively after 6 months when the epithelial 
defect was completely healed and they attained good visual acuity.   
 There was no ectasia of cornea seen postoperatively during the 6 
months follow up. 
 There was no deterioration of vision or any late postoperative 
complication in both the groups. 
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Sex Distribution 
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Comparison of Best Corrected Visual Acuity Pre and Post Operatively 
in the Mild Myopic Group 
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Comparison of Best Corrected Visual Acuity  
Pre and Post operatively in the Moderate Myopic group 
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Reduction in the Spherical Equivalent following surgery 
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Correction of Mild myopia (< -5.00 Sph) after surgery 
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Correction of Moderate myopia (> -5.00 Sph) after surgery 
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DISCUSSION 
 
 Overall, many reports have shown excellent medical outcome of 
efficacy, predictability and safety after PRK. 
 
 In our study, when comparing the 6 months postsurgical corrected 
vision with the best presurgical visual performance in two groups, patients 
described themselves as satisfied, with the mean presurgical BCVA being 
0.16 with a SD +/-0.12 and postoperative UCVA 0.95 with a SD +/-0.132 in 
the low myopia group. 
 
Mean BCVA   :  0.76 SD +/-0.021 
Postoperative mean UCVA :  0.94 SD +/-0.18 
 
Moderate group: 
 
 The overall predictability was 100% in the mild and moderate group 
A similar study was done in REMUERA Eye Clinic, Auckland, New 
Zealand. Uncorrected visual acuity of 20/20 was achieved in 59% of eyes 
and of 20/40 or better in 94%. The accuracy of correction was ±0.5 D of 
emmetropia in 77% and ±1.0 D in 94%. In 2 eyes (1.0%), corneal haze 
was assessed as 2+ and 2 Snellen lines of best corrected visual acuity 
were lost. The questionnaire revealed that 45% of patients had difficulties 
with night vision. This was better than before surgery in 35% but worse in 
31%. Halos were seen around lights by 52%, but these were less than 
before surgery in 21% and worse in 26%. There was undue sensitivity to 
glare in 29%, but this was better than before surgery in 19% and worse in 
28%. The overall quality of vision was better than before surgery in 60% 
and worse in 17%. Seventy-seven percent did not need spectacles. 
Ninety-eight percent said they would have the surgery again.  
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In our study, PRK was performed using Mel 80 Excimer laser 
system.  Compared to our results, other studies conducted on other laser 
systems showed similar results. Ninety-two eyes myopic eyes of 55 
patients were treated with a single-step method using an Aesculap-
Meditec MEL 60 excimer laser with a 5.0 mm ablation zone. The study was 
conducted by J. Pietila, P.Makinan, T. Pajari et al. and the results were 
published online in the Journal of Refractive Surgery in August 2004.  
Treated groups were divided into three groups according to preoperative 
refraction: low myopes (≤6.00D), medium myopes (−6.10 to −10.00D), and 
high myopes (>10.00D). Myopic regressions stabilized in all three groups 
within 12 months, although there was a small myopic shift of −0.42 ± 0.48D 
for low myopes, −0.37 ± 0.34D for moderate myopes, and −0.41 ± 0.50D 
for high myopes between 2 and 8 years after PRK. The percentage of eyes 
within ±1.00D of emmetropia 8 years after PRK was 78.3% in the low 
myopia group, 68.8% in the moderate myopia group, and 57.1% in the 
high myopia group. The percentage of eyes with uncorrected visual acuity 
of 20/40 or better was 78.3%, 62.5%, and 57.1%, respectively  
 
 In our study done using Mel 80 Excimer laser system, the mean 
spherical equivalent in low myopia was –3.07 with a SD +/-2.3 and the 
mean postop spherical equivalent was –0.1814 with a SD +/-0.32 after 6 
months. 
 The mean preoperative spherical equivalent in moderate myopes 
was –9.15 with a SD +/-3.3 and postoperative spherical equivalent was –
0.386 SD +/-0.75. 
 
39 
 50
 A similar study was done by Hasan Hashemi, Seied Mohammad 
Reza Taheri et al. published in BMC Ophthalmology 2004 studied 54 eyes 
of 28 myopic patients in a prospective study.  All eyes were operated by 
PRK followed by 0.02% mitomycin-C application for two minutes and 
washed with 20 ml of normal saline afterwards.  The mean spherical 
equivalent was –7.08 D with SD +/-1.11 preoperatively.  Six months after 
surgery, 37 eyes (77.1%) achieved a UCVA of 20/40 or better and 45 
(93.7%) eyes had SD +/-1.0 D.  One month postoperatively, 2 eyes (3.7%) 
had grade 0.5+ of haze (Hanna grading in the scale of 0 to 4+) while at 3 
and 6 months after surgery, no visited eye had haze at all.  All eyes had a 
BCVA of 20/40 or better and there were no lost lines in BCVA by 6 months 
after surgery similar to our study. 
 
 A long term study after PRK- 12 year follow up – done by Madhavan 
S. Rajan MRCO, FRCS and Philip Jaecock MRCO published in 
Ophthalmology 2004;111:1813-1824 studied 68 patients (56.6%) of the 
original cohort of 120 who participated in the first UK Excimer laser clinical 
trial.  They underwent a detatched clinical assessment at 12 years after 
myopic PRK- myopic PRK was performed using Summit Technology 
UV2000 Excimer laser with a 4 mm ablation zone.  Patients were allocated 
to one of six treatment groups.  Each group received one of the following 
spherical aberrations -2,  -3, -4, -5, -6 or –7 D.  The postoperative 
refraction remains stable at 12 years with no significant change in the 
spherical equivalent refraction between 1, 6 and 12 years. 
 
 75% of patients who underwent a –2 D correction and 65% of 
patients who received a –3 D correction were within 1 D of intended 
correction at 12 years. 
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 57% -4D and 50% -5 D were within 1 D of intended correction at 12 
years. 
 
 Of 25% -6 D and 22% -7 D respectively, 4% had residual corneal 
haze and 12% had persistent nighttime haloes at 12 years.  Dry eyes were 
encountered in 3% of patients and none of the eyes developed corneal 
ectasia in long term follow up which was similar to our group. 
 
 As long as patients are informed of the limitations of PRK for 
myopia, the results are acceptable. 
 
STABILITY 
 
 The stability of vision was maintained throughout the 6 months follow 
up in both groups.   
 In moderate myopia, the preoperative mean UCVA was 0.076 which 
was comparable to postoperative UCVA of 0.94 which remained stable 
and is statistically significant. 
 5 eyes of 3 patients in moderate myopia group whose preoperative 
visual acuity was between 6/36 and 6/9 did not show any improvement 
after the procedure or with final refraction and were found to be amblyopic. 
 24 eyes of 12 patients developed epithelial defect intraoperatively.  
All 24 developed stromal haze in the immediate postoperative period, but 
on follow up at 6 months, no visited eye was found to have stromal haze.  
There was no retreatment done on any of the patients.  None of the eyes 
developed corneal ectasia.  
 Importantly, the safety profile of PRK using Mel 80 Excimer laser in 
this study is excellent. 
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SUMMARY  
 
 
In this prospective study, 90 eyes of 45 patients underwent PRK with 
Mel 80 Excimer laser system of which 46 eyes were of low myopia and 44 
eyes were of moderate myopia. 
 
¾ Preoperative uncorrected visual acuity, BCVA, spherical 
equivalent, topography, corneal thickness, keratometry and 
pupil diameter were recorded for all the patients.   
¾ PRK was done for all the patients in an attempt to achieve the 
preoperative BCVA. 
¾ Postoperative UCVA was recorded for all the patients on Day 
1,   3day  and six months   
¾ Pre-operative and post-operative BCVA was compared which 
was found to be statistically significant. 
¾ There was no postoperative decrease in vision during the 6 
months followup. 
¾ There was no retreatment in this study 
¾ Importantly, the safety profile of PRK was found to be 
excellent. 
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CONCLUSION 
 
 The findings in this study are significant, showing good unaided 
postoperative visual acuity with excellent safety profile.  Overall patient 
satisfaction with this procedure is high with Mel 80 laser system, which is 
comparable to other 5th generation laser systems.  The emergence of 
better laser nomograms, larger optical zones and improved understanding 
of aberrations and their significance will lead to improvements in patient 
outcome in future. 
 
 PRK can be considered an alternative treatment procedure for 
myopic patient whose corneal   thickness  is  inadequate for laser in situ   
keratomileusis (LASIK). 
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PROFORMA 
 
VISUAL OUTCOME OF PRK IN LOW TO MODERATE MYOPIA 
 
NAME OF PATIENT:    AGE:  SEX: 
 
OCCUPATION:      IP No.: 
 
DATE OF ADMISSION: 
 
DATE OF OPERATION: 
 
DATE OF DISCHARGE: 
 
HISTORY: 
 
COMPLAINTS 
 
 
History of: 
 
1. Wearing spectacles- Duration, last change of glasses 
2. Wearing contact lens- Duration, type (soft/rigid/gas permeable 
PMMA) 
3. Previous refractive surgery 
4. Disease of the eye 
5. Any allergy 
6. Previous squint surgery, RD surgery, Laser for retinal holes 
7. Pregnancy/ Lactation 
8. Social history- Occupation 
9. Medical History 
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OCULAR EXAMINATION  
 
1. Uncorrected Visual Acuity- Distant Vision: Aided 
     Unaided 
        Refraction 
2. Lids and Adnexa- Chalazion, Blepharitis, Stye 
3. Palpebral fissure- Deep socket, Prominent eyes 
4. Squint, Nystagmus 
5. Conjunctiva- Scarring, Pterygium, Papillae 
6. Cornea- Size of the cornea, Clarity, Vascularisation 
7. Anterior Chamber 
8. Pupil- Size, Shape, Reaction 
9. Lens- Opacities,Subluxation 
 
INVESTIGATIONS: 
 
1. Slit lamp examination- including IOP measurement 
2. Corneal Topography- irregular astigmatism  
3. Ultrasound pachymetry 
4. Indirect Ophthalmoscopy 
5. Tear film Stability 
6. WASCA aberrometry- 3rd, 4th aberrations pupil size in dark 
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VISION    RE    LE  
 
 
Distant vision- unaided  
 
    with pinhole 
 
 
Refraction     - with correction 
 
 
AR 
 
 
BCVA 
 
 
Near vision- unaided  
 
                   With correction 
 
 
PROCEDURE 
 
 
 
POST OPERATIVE EVALUATION 
 
1 hour after PRK – VA, refraction, SL Examination 
 
3 days 
 
3 months 
 
6 months 
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                       Mild Myopia (-1 D - -5 D)  
S.NO NAME   AGE SEX PREOPRISION BEST CORRECTED VISUAL ACUITY TOPOGRAHY   IMMEDIATE POST OP FOLLOWUP VISION POST OP BCVA
              RETINOSCOPY   SPHERICAL VISION RE LE PREOP PACHYMETRY PUPIL SIZE INTRA OP POST OP VA COMP. 1 HOUR 3 DAYS 6 MONTHS RE LE   
          RE LE RE LE RE LE RE LE K 1 K 2 K 1 K 2 RE LE RE LE COMP RE LE   RE LE RE LE RE LE   
1 Abirami 477847 28 F 6\60 6\60 -4.5 -4.5 -4.5 -4.5 6\6 6\6 43.75 43.75 43.87 43.37 459 456 6.77 6.27   6\9 6\9   6\9 6\9 6\9 6\9 6\6 6\6 0 6\6 0 6\6   
2 Samyukta 477617 24 F 6\36 6\60 4.75\.5cyl80                             -4,5\.5cyl160   -5 -5 6\6 6\6 46.75 45.62 46.62 45.87 499 490 4.82   epithelial 6\9 6\9 stromal 6\9 6\9 6\9 6\9 6\6 6\6 0 6\6 0 6\6   
3 Muthamil 49779 33 F 5\60 6\60 -4,00\'-0.75 cyl 30 -2.25\'-1cyl70 -4.25 -2.75 6\6 6\6 40.12 39.37 45.37 45.37 433 500 5.68 5.34 epithelial 6\8 6\9 stromal 6\8 6\9 6\8 6\9 6\9 6\6 -1 6\6 -0.5 6\6   
4 Hemalatha 513102 22 F 6\60 6\60 -2 -1.5 -2 -1.5 6\6 6\6 44 44 43.87 43.5 549 564 6.53 6.58   6\6 6\6   6\6 6\6 6\6 6\6 6\6 6\6 0 6\6 0 6\6   
5 Jarvis 53527 18 M 5\60 5\60 -4.75\'-0.5cyl 180 -4.75\'-0.74cyl 180 -5 -5 6\6 6\6 45.12 43.75 45.12 43.87 487 505 6.76 6.71 epithelial 6\6 6\6 stromal 6\6 6\6 6\6 6\6 6\6 6\6 0 6\6 0 6\6   
6 Chindanaiselvi 493216 20 F 6\24 6\9 -2.25 -2.25 -2.25 -2.25 6\6 6\6 45 44 45.37 44.75 474 500 5.68 5.93 epithelial 6\12 6\6 stromal 6\12 6\6 6\9 6\6 6\6 6\6 0 6\6 0 6\6   
7 Sujata 494223 30 F 5\60 5\60 -4.50\'-0.50 cyl 10 -4.50 -4.75 -4.5 6\6 6\6 43.12 43.12 43.75 43.62 476 493 5.2 4.93 epithelial 6\18 6\24 stromal 6\18 6\24 6\9 6\12 6\6 6\6 0 6\6 0 6\6   
8 Arun Kumar 583575 29 M 5\60 5\60 -3.0\ '-1.5 cyl 180 -3.0\ '-1.5 cyl 180 -3.75 -3.75 6\6 6\6 43.87 42.87 44 42.75 503 499 5.33 5.69 epithelial 6\6p 6\6p stromal 6\6 6\6p 6\6 6\6p 6\6 6\6p 0 6\6 -0.5 6\6p   
9 Manivannan 584571 17 M 4\60 4\60 -3.5\'-0.25 cyl 180 -3.5\'-0.25 cyl 180 -3.5 -3.5 6\9 6\9 43.65 4.62 43.25 41.75 505 502 6.85 7.01 epithelial 6\9 6\9 stromal 6\9 6\9 6\9 6\9 6\9 6\9 -0.5 6\9 -0.5 6\9   
10 Karthickeyan 590407 20 M  6\60 6\60 -3.0\'-0.50 cyl 30 -3 -3.25 -3 6\6 6\6 45 43.62 44.62 43.01 531 524 6.01 6.64 epithelial 6'6p 6\6p stromal 6\9 6\9 6\9 6\9 6\9 6\9 -0.5 6\6 -0.5 6\6   
11 Senthil Kumar 596781 29 M 6\36p 6\36p -1.50\ '-3.0 cyl 90 -2.0\'2.5 cyl 90 -3 -3.5 6\12 6\12 46.62 43.25 45.27 43.75 490 493 6.08 5.4 epithelial 6\18p 6\18p stromal 6\18p 6\18p 6\18p 6\18p 6\18p 6\18p -1 6\18 -1 6\18   
12 Ventketesan 600117 26 m 6\24 6\24 -3.00\-.5 cyl 90 -3 -3.25 -3 6\6 6\6 44.62 44.62 44.87 44.75 480 473 6.99 6.86  6\6 6\6  6\6 6\6 6\6 6\6 6\6 6\6 0 6\6 0 6\6   
13 Mathankumar  5940118 22 M 6\24 6\24 -2.5\-.5 cyl 90 -2.5\-.5 cyl 50 -3 -3.5 6\6 6\6 43.62 43.25 44.25 43.5 547 536 6.82 6.71  6\6 6\6  6\6 6\6 6\6 6\6 6\6 6\6 0 6\6 0 6\6   
14 Subashini 570862 25 F 6\36 5\60 -3\-1.5 cyl 180  -4.5\-2 cyl 180 -4.25 -5.25 6\6P 6\6P 45.62 43.25 45.12 43.62 520 518 7.41 7.08 epithelial 6\9 6\9 stromal 6\9 6\9 6\9 6\9 6\9 6\9 -0.5 6\6 -0.5 6\6   
15 Shoba 573408 21 f 6\60 6\60 -4.5 -4.5 -4.5 -4.5 6\6 6\6 44 43.37 44 43.12 467 455 6.42 6.56  epithelial 6\6p 6\6 stromal 6\6p 6\6 6\6p 6\6 6\6p 6\6 -0.5 6\6p 0 6\6   
16 Amutharani 569010 28 f 3\60 3\60 -4.75\-1.5 cyl 170 -6.5 5.5 6.5 6\6 6\6 47.87 46.12 47.75 46.5 510 513 5.32 5.49  6\6 6\6  6\6 6\6 6\6 6\6 6\6 6\6 0 6\6 0 6\6   
17 Bilal Mohammed 519910 23 m 6\24 6\24 -2.5 -2.5\-.5 cyl 100 -2.5 -2.75 6\6 6\6 43.75 43.37 43.37 43.12 480 481 5.87 6.72  6\6 6\6  6\6 6\6 6\6 6\6 6\6 6\6 0 6\6 0 6\6   
18 Sheela 532156 23 f 6\60 6\60 -3.25 -2\-3 cyl 15 -3.25 -3.5 6\6 6\6 48.12 45.12 48.37 44.37 479 492 5.9 5.68 epithelial 6\12 6\9 stromal 6\12 6\6 6\9 6\6 6\9 6\6 -1 6\6p 0 6\6   
19 Jeyakanth 561467 23 m 6\24 6\12 -1.25\-.75 cyl 180 -.75\-1 cyl 180 -1.5 -1.25 6\6 6\6 42.37 42.12 43.37 42.25 579 582 7.21 7.35  6\6 6\6  6\6 6\6 6\6 6\6 6\6 6\6 0 6\6 0 6\6   
20 Ramesh 558502 19 M 5\60 5\60 -5\-.5 cyl 180 -5\-.5 cyl 180 -5.25 -5.75 6\6 6\6 48 47 47.5 46.62 517 500 6.36 6.07 epithelial 6\6 6\6   6\6 6\6 6\6 6\6 6\6 6\6 0 6\6 0 6\6   
21 Saranya  5901102 27 F 6\60 6\60 -1.75\-1.25 cyl 180 -1.75\-1.25 cyl 180 -225 -2.25 6\6 6\6 46.75 44.5 46.25 44.75 472 480 6.36 4.88  6\6P 6\6P  6\6P 6\6P 6\6P 6\6P 6\6 6\6 0 6\6 0 6\6   
22 Saranya Madhavan 580013 20 f 6\18 6\18 -2.5 cyl 180 -2.5 cyl 180 -1.25 -1.25 6\6 6\6 45.37 43.62 44.75 42.87 479 482 5.7 5.88 epithelial 6\12 6\12 stromal 6\12 6\12 6\12 6\12 6\6 6\6 0 6\6 0 6\6   
23 Uma Maheshwari 602419 24 f 6\24 6\24 -3\-.75 cyl 90 -4 -4.25 -4 6\6 6\6 46.11 46.87 46.87 46.62 479 485 6.66 6.99  6\6 6\6  6\6 6\6 6\6 6\6 6\6 6\6 0 6\6 0 6\6   
                                           
                      Moderate Myopia (-5 D - -12 D)  
S.no Name MR no. Age  Sex Pre op Vn Best corrected visual acuity Topography Pre op Pachymetry Pupil Size Intra op Immediate Post op. P. Comp. Follow up Visual acuity Post Op. BCVA
     RE LE Retinoscopy value Spherical Equiv Visual Acuity RE LE RE LE RE LE Comp RE LE 1 hr 3 days 6 months RE LE
       RE LE RE LE RE LE K1 K2 K1 K2  RE LE RE LE RE LE     
1 Vigneshwaralu 469882 19 M 4\60 5\60 -8 -5 -8 -5 6\6 6\6 46.12 44.87 45.62 44.75 464 437 7.27 7.54 epithelial 6\18 6\18 stromal 6\18 6\18 6\9 6\9 6\6 6\6 0 6\6 0 6\6 
2 Diana Joseph 484506 23 F 5\60 5\60 -12\' -1.5 cyl 180 -20\'-2 cyl 180 -12.75 -21 6\6 6\36 45.12 43 46.12 44.12 474 485 6.82 6.3 epithelial 6\9 6\36 stromal 6\9 6\36 6\9 6\24 6\6 6\24 -1 6\6 -4 6\24
3 Caroline 476061 26 F 5\60 5\60 -5\'-2.5 cyl 180 -7\'-2 cyl 180 -6.25 -9 6\6 6\6 44.62 42.87 44.75 42.87 527 520 4.87 5.71  6\6p 6\6p  6\6 6\6 6\6 6\6 6\6 6\6 0 6\6 0 6\6 
4 Srisakthi 446990 22 F 5\60 5\60 -5.5 -5.5\-0.5 cyl 170 -5.5 -6 6\6 6\6 46.5 45.62 46.37 46 488 489 7.21 7.58  6\18 6\18 stromal 6\12 6\12 6\6 6\6 6\6 6\6 0 6\6 0 6\6 
5 Pankajavalli 552952 43 F `5\60 5\60 -10/'-1.0 cyl 180 -9 -10.5 -9 6\6p 6\6p 44.62 43.87 45.25 44.37 513 500 6.88 6.43 - 6\24 6\9  6\18 6\9 6\12 6\9 6\12 6\9 -1 6\6 -0.5 6\6 
6 Balamurugan 550234 38 M 5\60 5\60 -8\'-1.5 cyl 180 -11\ '0.75 cyl 80 -8.75 -11.25 6\9 6\12 44.25 43.25 43.62 42.75 570 567 3.48 3.68 epithelial 6\12p 6\12p stromal 6\12 6\12 6\9 6\9 6\9 6\9 -0.5 6\6 -0.5 6\6 
7 Manonmani 546101 19 F 5\60 5\60 -4.75\-1 cyl 180 -6 -5.25 -6 6\6 6\6 44.37 43.12 44.37 43.87 496 502 6.5 6.62 epithelial 6\6p 6\6p - 6\6p 6\6p 6\6 6\6 6\6 6\6 0 6\6 0 6\6 
8 Priya 543135 19 F 5\60 5\60 -6\-0.75 cyl 90 -6\-0.5 cyl 90 -6.25 -6.25 6\6 6\6 47.37 46.62 47.87 47.62 529 527 5.4 6.15 epithelial 6\6p 6\6p stromal 6\6p 6\6p 6\6 6\6 6\6 6\6 0 6\6 0 6\6 
9 Deepa 542204 23 F 5\60 5\60 -7\-3 cyl 180 -8\-1.5 cyl 180 -8.5 -9.25 6\9 6\9 47.5 45.37 47 45.75 460 459 5.86 5.86  6\9 6\9  6\9 6\9 6\9 6\9 6\6p 6\6p -0.5 6\6 -0.5 6\6 
10 Punitha 534126 25 F 4\60 6\60 -11\-3 cyl 180 -7.5\-3 cyl 160 -12.5 -9 6\9 6\9 44.45 41.37 44 41.5 520 506 5.7 5.6  6\9 6\9  6\9 6\9 6\9 6\9 6\6 6\6 0 6\6 0 6\6 
11 Surendar 521775 24 M 5\60 5\60 -7\-0.75 cyl 90 -6.5 -7.5 -6.5 6\6p 6\6p 44.5 44 44.62 44.37 485 481 6.51 6.24  6\6p 6\12p  6\6p 6\12p 6\6p 6\12p 6\6 6\6 0 6\6 0 6\6 
12 Franklin 523629 24 M 5\60 5\60 -10\-0.75 cyl 75 -7\-0.5 cyl 120 -10.25 -7.25 6\9p 6\6p 42.87 42.87 43.12 42.5 487 482 5.67 4.86 epithelial 6\6p 6\6p  6\6p 6\6p 6\6 6\6 6\6 6\6 0 6\6 0 6\6 
13 Reshmi 519533 22 F 5\60 5\60 -7\-1.5 cyl 170 -5\-0.75 cyl 30 -8.75 -5.25 6\6 6\6 51 48.87 50 48.7 520 516 6.54 6.42 epithelial 6\9 6\9 stromal 6\9 6\9 6\9 6\9 6\6 6\6 0 6\6 0 6\6 
14 Karthickeyan 556781 21 M 2\60 2\60 -13\-1 cyl 40 -12 -14 -12 6\6 6\9 45.25 45 45.62 44.37 517 520 5.4 5.5 epithelial 6\9 6\18 stromal 6\9 6\18 6\9 6\18 6\9 6\18 -0.5 6\6 -1 6\6 
15 Thilakavathy 596450 22 F 5\60 5\60 -6\-0.75 cyl 170 -6\-0.75 cyl 170 -6.25 -6.25 6\9 6\9 45.75 44.87 45.5 44.62 491 489 5.7 5.71 epithelial 6\9 6\9 stromal 6\9 6\9 6\6 6\6 6\6 6\6 0 6\6 0 6\6 
16 Vijayalakshmi 596708 43 F 5\60 5\60 -5\-1 cyl 90 -6\-0,5 cyl 90 -5.5 -6.25 6\6p 6\6p 46.12 44.5 45.62 45.12 478 482 6 6.14 - 6\6p 6\6p - 6\6p 6\6p 6\6p 6\6p 6\6p 6\6p -0.5 6\6p -0.5 6\6p
17 Dhanalakshmi 573866 24 F 5\60 5\60 -12\-2 cyl 90 -14\-2 cyl 90 -13 -15 6\9 6\9 45 43.5 45 43.62 518 516 6.25 6.15 epithelial 6\12 6\12 stromal 6\12 6\12 6\9 6\9 6\9 6\9 -1 6\9 -1.5 6\9 
18 Sembharathy 589801 20 M 5\60 5\60 -9 -8\-1 cyl 180 -9 -8.5 6\6 6\6 45 44 45.75 44.6 514 522 6.71 6.81  6\6p 6\6p  6\6p 6\6p 6\6 6\6 6\6 6\6 0 6\6 0 6\6 
19 Bharathi 582434 38 F 3\60 5\60 -8.5\-2 cyl 180 -6\-2 cyl 180 -9.5 -7 6\6p 6\6p 44.62 42.87 44.12 42.5 498 491 6.19 6.06  6\6p 6\6p  6\6p 6\6p 6\6 6\6 6\6 6\6 0 6\6 0 6\6 
20 Rani 581929 32 F 6\60 6\60 -13\-0.5 cyl 180 -9.5\-1.25 cyl 90 -14 -10.25 6\12 6\9 44.75 44.62 46 44.5 480 479 5.17 5.09 epithelial 6\18 6\12 stromal 6\18 6\12 6\18 6\12 6\18 6\12 -2 6\18 -1.5 6\12
21 Parimala 576659 33 F 6/60 0.1 6\60 -9.5 -9.5 -9.5 -9.5 6\6 6\6 48 47.5 48.62 47.37 492 511 5.54 5.62  6\9 6\9  6\9 6\9 6\6 6\6 6\6 6\6 0 6\6 0 6\6 
22 Rajesh 582192 23 M 2\60 2\60 -13\-1.5 cyl 40 -11\-1 cyl 60 -13.75 -12 6\9 6\9 47.5 46 47.12 46.25 519 502 7.56 7.35 epithelial 6\12 6\12 stromal 6\12 6\12 6\12\ 6\12 6\6p 6\6p 0 6\6 0 6\6 
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LASIK CENTRE INSITUTE OF OPHTHALMOLOGY JOSEPH   EYE 
HOSPITAL  INFORMED CONSENT FOR EXCIMER LASER SURGERY 
 
Patient Name 
       The information detailed in this “CONSENT FORM” is provided so that 
a person interested in Excimer laser surgery can make an informed 
decision .Please read the form carefully and clarify  all doubts that’s you 
may have before undergoing the procedure. 
 
What is LASIK  
        Lasik (or laser assisted in situ keratomilueusis) reshapes the cornea 
the clear front surface of the eye. Using the precision of computer 
controlled excimer   laser, Lasik alters the shape of the cornea and 
improves the focus of image by the eye. This technique is very safe and 
excellent results. The aim of Lasik   surgery is to bring down dependency 
over spectacles or contact lens. Lasik is an elective procedure. 
Lasik   Procedure 
        This is performed under optical anaesthesia. A thin flap of corneal 
tissue is made using a specialized microkeratome. Laser spots are applied 
on the corneal surface under the flap and the flap and the flap is placed 
back after the procedure. Patient’s co-operation is very important for the 
success of this surgery and the patient will, be required to his/her gaze at a 
blinking light to ensure proper centration. Patient may feel some pressure, 
but no pain on his/her eye just before the microkeratome  
Flap is raised .A clicking sound is heard during the procedure  
 
PATIENT CONSENT  
            In giving permission for using the microkeratome and excimer 
laser, you have received no guarantee as to success of your particular 
case. You should be aware that few risks though uncommon are 
associated with the procedure. 
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1. Malfunction of the microkeratome or excimer laser unit may require 
the procedure to be stopped before completion. 
2.  If the flap rose is not to the required precision levels surgery may 
have to be postponed and results and rescheduled after 2-3 
months. 
3. If the patient co-operation is inadequate, surgery may have to be 
postponed 
4. Rare possibility of sight threatening infection as with all other 
surgical procedures is present. 
5. Glares haloes and fluckation in sharpness of vision may be 
experienced for the 2-3 months  by some   
6. Calculations used in this surgery are based on previous 
experience on large numbers of patient thus depending on 
individual variation in response to the procedure there might be 
some under correction. 
7. I understand that as I get older (40 years or older), I may require 
reading glasses which is normal eye related change. 
8. Very rare complication of this  procedure include serve corneal 
edema, loss of corneal flap which may require appropriate 
management such as corneal transplant or in exceedingly rare 
cases lead to partial or complete loss of vision in the eye.  
9. As this technique has been in practice for less than two decades, 
long term affects of this procedure are not known. 
    
       I under stand that although an attempt has been made to give a 
complete list in this list does not include every possible side effect, risk and 
complication Lasik /Excimer PRK /PTK. 
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        I here by consent to release / publish medical data of the procedure 
are the subsequent treatment for purpose of research and advancement of 
medical knowledge. 
 
     In signing this consent for Lasik / Excimer PRK, / PTK I state to have 
read the form and understand the nature purpose and possible side 
effects, risks and complication of Lasik / Excimer, PRK / PTK. Also I have 
had all my queries answered to my satisfaction. I give permission to Dr.                         
To   perform Lasik   Excimer  PRK  PTK. Procedure on my                                  
 
 
 
Date                                                                    Patient Signature  
    
 
Name:                                                                  Witness Signature 
 
 
 
 
 
Date                                                                    Witness Signature 
                                                               
 
Name:                                                                 
 
 
 
Date of Surgery                                                   Signature of surgeon. 
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LASIK CENTRE 
INSITUTE OF OPHTHALMOLOGY 
JOSEPH   EYE HOSPITAL 
PATIENT INSTRUCTION FOR LASIK 
 
 
 
 
DATE                                                                      TIME 
 
 
Patient’s Name 
 
 
Prior to surgery: 
 
Discontinue contact lens wear in the to be treated for at least 10 
days for the soft lenses and  21days for gas permeable rigid 
contact lenses or hard lenses. 
 
Do not use Mascara o r eyeliner for 3 days prior to surgrey 
 
Confirm the data and time of surgery and arrange payment for 
your surgical fee before the procedure. 
 
The surgical fees for Lasik inclusive of investigation will be 
Rs.15000/- for both eyes and Rs 8000/- for one eye. 
 
Arrange for transport on the day of surgery if residing in Trichy or 
come prepared for one day in patient stay 
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THE DAY OF YOUR TREATMENT 
 
Please arrive on time. 
 
Wear comfortable clothing. Please do not wear perfume, cologne, 
flowers, and after shave as these may interfere with laser. 
Please do not wear eye makeup on the treatment. 
 
Eat a light meal before your appointment. 
 
Please bring the following items: a copy of these instructions. 
 
AFTER SURGERY 
 
You can go home and relax on the day of treatment. 
 
You should come for follow up the next day to LASIK CENTER at 
2.00 pm. 
 
Avoid going to dusty place for a period of one week. 
 
You can read, work on computes or watch television after 2or 3 
days. 
 
You can take head bath after a week. 
 
DO NOT RUB YOUR EYES FOR ONE MONTH AFTER 
SURGERY 
 
The following medicine must be used as directed. 
 
FML drops for 4 times for 5 days. 
Ocucin drops for 4times for 5 days. 
Refresh tears for 3 times for 1 month. 
 
 
It is advisable to wear eye protective sun glasses for a month 
when you go out. 
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Do not use Mascara or eye liner for week after surgery. 
 
It is normal experience any of following the redness, light 
sensitivity irritation, fluctuating pain for several day after 
treatment. 
  
Vision begins to improve with in 24 hours after surgery, but may 
fluctuate for several weeks. Glare and haloes may be present at 
night but these usually diminish over weeks to month  
 
If there is any unbearable pain, redness or defective vision, kindly 
contact. 
 
LASIK CENTRE 
JOSEPH   EYE HOSPITAL 
TIRUCHIRAPPALLI 620001 Ph 2460622, 2462862 
 
The exact refractive status will be assessed one month after 
surgery 
 
Patient has to come for Is’ month post – op. preferably on Friday 
or Saturday after 2.00pm 
 
 
 
                                                               
  
 
56 
